HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CGS 22652

has thromboxane receptor antagonism combined with thromboxane synthase inhibition; structure given in first source
Also Known As:
8-(((4-chlorophenyl)sulfonyl)amino)-4-(3-(3-pyridinyl)propyl)octanoic acid; 8-((4-chlorophenylsulfonyl)amino)-4-(3-(3-pyridinyl)propyl)octanoic acid; 8-CSAPOA; CGS-22652
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Marrache, A M: 1 article (06/2001)
2. Martinez-Bermudez, A K: 1 article (06/2001)
3. Abran, D: 1 article (06/2001)
4. Chemtob, S: 1 article (06/2001)
5. Roberts, J: 1 article (06/2001)
6. Gobeil, F: 1 article (06/2001)
7. Varma, D R: 1 article (06/2001)
8. Almazan, G: 1 article (06/2001)
9. Hou, X: 1 article (06/2001)
10. Lachapelle, P: 1 article (06/2001)

Related Diseases

1. Hyperoxia
2. Renovascular Hypertension (Goldblatt Syndrome)
3. Coronary Thrombosis

Related Drugs and Biologics

1. Retinaldehyde (Retinal)
2. 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid
3. salicylhydroxamic acid (SHAM)

Related Therapies and Procedures

1. Surgical Instruments (Clip)